AGMB-447

AGMB-447 · Agomab Spain S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGMB-447, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF [Phase 1]

See pricing